Page 1 of Clinical Trials for unresectable gastric cancer, 134 Total Matches

Show/Hide Clinical Trials Which are Not Seeking New Volunteers

1
Completed
Study of Cediranib Plus Cisplatin Plus Capecitabine/S-1 in Japanese Gastric Cancer Patients
Last Updated: June 13, 2011
Condition(s): Gastric Cancer
2
Completed
Phase III Trial of DP Followed by FOLFIRI or the Reverse Sequence in Unresectable Gastric Cancer
Last Updated: January 10, 2012
Condition(s): Gastric Cancer; Metastases
3
Recruiting
Oxaliplatin and S-1 or Oxaliplatin and Capecitabine in Treating Patients With Recurrent, Metastatic, or Unresectable Gastric Cancer
Last Updated: October 19, 2011
Condition(s): Gastric Cancer
4
Completed
Capecitabine Versus S-1 in Elderly Advanced Gastric Cancer (AGC): Randomized Trial
Last Updated: February 11, 2010
Condition(s): Gastric Cancer
5
Recruiting
Study of Modified Docetaxel, Cisplatin, and Fluorouracil (mDCF) in Unresectable or Metastatic Gastric and Gastroesophageal Junction Adenocarcinoma
Last Updated: May 23, 2012
Condition(s): Gastroesophageal Junction Adenocarcinoma; Gastric Cancer
6
Not yet recruiting
XParTS II: Capecitabine/CDDP(XP) and S-1/CDDP(SP) as the First-line Treatment for Advanced Gastric Cancer
Last Updated: August 18, 2011
Condition(s): Gastric Cancer
7
Recruiting
Sequential Chemotherapy With Xelox Follows by TX to Treat Gastric Cancer
Last Updated: April 7, 2011
Condition(s): Gastric Cancer
8
Completed
Phase II Study of ABI-007 for Gastric Cancer
Last Updated: January 16, 2012
Condition(s): Gastric Cancer
9
Active, not recruiting
Trial of 3-weekly Versus 5-weekly Schedule of S-1 Plus Cisplatin in Gastric Cancer
Last Updated: September 28, 2011
Condition(s): Advanced Gastric Cancer
10
Completed
A Phase I/II Trial of Docetaxel and Oxaliplatin in Patients With Advanced Gastric Cancer
Last Updated: January 12, 2009
Condition(s): Gastric Cancer
11
Active, not recruiting
Study of Irinotecan and Docetaxel in Patients With Metastatic or Unresectable Gastric or Gastroesophageal Junction Adenocarcinoma
Last Updated: February 1, 2012
Condition(s): Gastric Cancer; Esophageal Neoplasms
12
Active, not recruiting
Study of Oxaliplatin and Xeloda and Cetuximab as First Line Treatment for Metastatic or Unresectable Gastric or Gastroesophageal Junction Cancer
Last Updated: February 1, 2012
Condition(s): Gastric Cancer; Esophageal Cancer
13
Recruiting
Efficacy and Safety Study of a Modified SOX Regimen in First-Line Treatment of Unresectable Gastric Adenocarcinoma
Last Updated: March 27, 2012
Condition(s): Gastric Adenocarcinoma
14
Active, not recruiting
Sorafenib, Docetaxel, and Cisplatin in Treating Patients With Metastatic or Locally Advanced Gastric or Gastroesophageal Junction Cancer That Cannot be Removed By Surgery
Last Updated: March 8, 2012
Condition(s): Gastric Cancer
15
Completed
Study of Ixabepilone in Asian Subjects With Unresectable or Metastatic Gastric Cancer
Last Updated: July 18, 2011
Condition(s): Stomach Neoplasms
16
Recruiting
Efficacy of Docetaxel, Capecitabine, Cisplatin, and Bevacizumab in Patients With Unresectable Advanced Gastric Cancer
Last Updated: November 10, 2011
Condition(s): Advanced Gastric Cancer
17
Completed
Imatinib, Capecitabine, and Cisplatin in Treating Patients With Unresectable or Metastatic Stomach Cancer
Last Updated: July 20, 2011
Condition(s): Gastric Cancer
18
Completed
Bortezomib in Treating Patients With Unresectable or Metastatic Gastric Cancer or Gastroesophageal Junction Adenocarcinoma
Last Updated: February 11, 2012
Condition(s): Gastric Cancer
19
Recruiting
Combination Chemotherapy and Bevacizumab in Treating Patients With Recurrent, Unresectable, or Metastatic Gastric Cancer, Gastroesophageal Junction Cancer, or Esophageal Cancer
Last Updated: July 7, 2009
Condition(s): Esophageal Cancer; Gastric Cancer
20
Recruiting
Everolimus in Treating Patients With Previously Treated Unresectable or Metastatic Esophageal Cancer or Stomach Cancer
Last Updated: April 5, 2011
Condition(s): Esophageal Cancer; Gastric Cancer

Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.

The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?term=unresectable+gastric+cancer

Page 1 of Clinical Trials for unresectable gastric cancer, 134 Total Matches

Get the Latest Results via Email or RSS

Subscribe via Web Newsreaders

Browse

Clinical Trials Background

About